Article
Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia
18 Jan 2022
Abstract excerpt
BACKGROUND: Chronic myeloid leukemia (CML) is a malignant hyperplastic tumor of the bone marrow originating from pluripotent hematopoietic stem cells. The advent of tyrosine kinase inhibitors (TKIs) has greatly improved the survival rate of patients with CML. However, TKI-resistance leads to the disease recurrence and progression. This study aimed to identify immune-related genes (IRGs) associated with CML...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
